Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
47.44
-4.15 (-8.04%)
At close: Jun 5, 2026, 4:00 PM EDT
47.08
-0.36 (-0.76%)
After-hours: Jun 5, 2026, 7:59 PM EDT
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Sales | 1.82B | 2.11B | 2.96B | 3.03B | 3.11B | 4.96B | 4.90B | 5.01B | |||||||||||||
| Product Sales Growth | -41.52% | -57.47% | -39.64% | -39.56% | -53.40% | -43.42% | -51.65% | -65.15% | |||||||||||||
| Grant and Collaboration | 126.00M | 121.00M | 120.00M | 149.00M | 127.00M | 117.00M | 149.00M | 143.00M | |||||||||||||
| Grant and Collaboration Growth | -0.79% | 3.42% | -19.46% | 4.20% | -28.25% | -69.53% | -73.10% | -80.17% |
| Period Ending | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | 1.15B | 1.58B | 1.66B | 1.73B | 2.28B | 1.98B | 1.82B | 1.72B | - | - | - | - | - | - | - | - | ||||
| United States Growth | -49.58% | -20.01% | -8.91% | 0.35% | 17.52% | -1.69% | -47.44% | -60.95% | - | - | - | - | - | - | - | - | ||||
| Rest of World | 653.00M | 802.00M | 798.00M | 810.00M | 1.79B | 2.21B | 2.41B | 3.60B | - | - | - | - | - | - | - | - | ||||
| Rest of World Growth | -63.48% | -63.63% | -66.94% | -77.49% | -53.39% | -47.31% | -57.24% | -50.70% | - | - | - | - | - | - | - | - | ||||
| Europe | 308.00M | 573.00M | 573.00M | 573.00M | 895.00M | 717.00M | 777.00M | 1.35B | - | - | - | - | - | - | - | - | ||||
| Europe Growth | -65.59% | -20.08% | -26.25% | -57.65% | -69.76% | -81.62% | -85.15% | -79.90% | - | - | - | - | - | - | - | - |
| Period Ending | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research and Development | 3.13B | 3.48B | 3.82B | 4.34B | 4.54B | 4.83B | 4.85B | 4.78B | |||||||||||||
| Research and Development Growth | -31.06% | -27.93% | -21.34% | -9.23% | -6.23% | 3.81% | 12.53% | 23.37% | |||||||||||||
| Selling, General, and Administrative | 1.02B | 1.06B | 1.07B | 1.11B | 1.17B | 1.29B | 1.45B | 1.52B | |||||||||||||
| Selling, General, and Administrative Growth | -13.29% | -17.94% | -26.13% | -26.75% | -24.21% | -11.07% | 12.71% | 29.85% |